Benlysta 120 mg powder for concentrate for solution for infusion*

Company

GlaxoSmithKline (Ireland) Ltd

Active Ingredient

• Belimumab

Dosage Form

Powder for Solution for infusion

Legal Category

A - prescription, may not be renewed

Date of revision

10/2026

*Additional information is available within the SPC or upon request to the company